Zimmer Biomet Holdings Inc represents a strong commitment to improving the quality of life for patients worldwide. With a focus on innovative medical solutions, Zimmer Biomet strives to provide effective and reliable orthopedic products and services. The company emphasizes integrity, collaboration, and excellence in everything it does, and aims to be a trusted partner for healthcare professionals. Zimmer Biomet's corporate philosophy revolves around delivering personalized treatment options, enhancing patient outcomes, and promoting sustainable healthcare solutions. By consistently pushing boundaries and investing in research and development, Zimmer Biomet aims to revolutionize orthopedic care and improve the lives of people around the globe.

Zimmer Biomet Holdings Inc is primarily present in various countries and regions around the world. Some of the key markets where this company operates include the United States, Europe, Asia-Pacific, and Latin America. With a strong global presence, Zimmer Biomet Holdings Inc has established itself as a leading player in the medical device industry. Its presence in multiple countries and regions allows the company to serve a diverse range of customers and cater to the healthcare needs of patients worldwide.

Zimmer Biomet Holdings Inc, a leading medical device company, has achieved significant milestones throughout its history. Firstly, the company's merger in 2015 between Zimmer Holdings and Biomet Inc increased its market presence and product portfolio. Zimmer Biomet has also introduced innovative products such as the Persona® Knee System, which offers personalized knee replacement options. Moreover, the company's ongoing commitment to research and development has led to advancements in surgical robotics and orthopedic implants. With its strong emphasis on patient outcomes, Zimmer Biomet has gained recognition for its quality systems and regulatory compliance. As a result, the company continues to establish itself as a trusted leader in the global healthcare industry.

Zimmer Biomet Holdings Inc, a leading global medical device company, has a rich history and background. It was formed in June 2015 through the merger of Zimmer Holdings and Biomet Inc. With a heritage dating back to 1927, Zimmer Biomet has been at the forefront of developing innovative solutions for orthopedic and musculoskeletal healthcare. The company focuses on providing products and services that enhance patients' quality of life, including joint reconstruction, spine and dental implants, sports medicine, and surgical technologies. Zimmer Biomet is committed to advancing medical science, improving patient care, and addressing the evolving needs of the healthcare industry.

Some of the main competitors of Zimmer Biomet Holdings Inc in the market include Johnson & Johnson, Stryker Corporation, and Medtronic plc.

Zimmer Biomet Holdings Inc is primarily active in the medical device industry. With a strong focus on orthopedic and musculoskeletal healthcare, Zimmer Biomet specializes in designing, manufacturing, and marketing a wide range of innovative and technologically advanced surgical products and solutions. The company's offerings include joint replacement systems, surgical implants, robotics-assisted technology, trauma products, and dental prosthetics. Zimmer Biomet has expertise in serving patients, healthcare professionals, and hospitals worldwide, aiming to improve patients' quality of life through its diverse portfolio of products and commitment to advancing healthcare technologies.

The business model of Zimmer Biomet Holdings Inc is focused on the research, development, and manufacturing of medical devices and orthopedic solutions. As a global leader in musculoskeletal healthcare, Zimmer Biomet provides innovative products and technologies for joint replacement, spine and trauma operations, dental implants, and sports medicine. The company collaborates with healthcare professionals to improve patient outcomes and enhance quality of life. Zimmer Biomet operates through three key segments: Orthopaedics, Dental, and Spine & CMF (Craniomaxillofacial). By consistently delivering advanced medical solutions, Zimmer Biomet aims to address the evolving healthcare needs of patients worldwide.

De Zimmer Biomet Holdings K/W is 13,56.

De Zimmer Biomet Holdings KUV is 2,91.

De AlleAktien Kwaliteitsscore voor Zimmer Biomet Holdings is 3/10.

De verwachte Zimmer Biomet Holdings omzet is 7,83 mld. USD.

De verwachte Zimmer Biomet Holdings winst is 1,68 mld. USD.

Zimmer Biomet Holdings Inc is a global leader in the medical device industry. The company offers a wide range of solutions for orthopedics, traumatology, spinal and dental surgery. Zimmer Biomet's orthopedic division produces a variety of products for use in knee, hip, shoulder, hand, elbow, and foot surgery. These products range from artificial joints and implants to surgical instruments and biological materials. Zimmer Biomet's traumatology division offers a wide range of products for the treatment of bone fractures, including fixation materials and devices for soft tissue reconstruction. Zimmer Biomet's spinal division focuses on the treatment of spine disorders, including herniated discs and spinal canal diseases. These products include spinal fusion systems and devices for minimally invasive spinal surgery. Zimmer Biomet's dental surgery division offers a wide range of implants, instruments, and materials for tooth and jaw reconstruction and rehabilitation. The business model of Zimmer Biomet aims to provide hospitals, clinics, and doctors with a comprehensive range of solutions for orthopedic, traumatology, spinal, and dental surgery applications. The company operates its business in over 100 countries worldwide and is committed to meeting the needs of its customers by investing continuously in research and development. Zimmer Biomet pursues a two-brand strategy with the Zimmer and Biomet brands. The company leverages its size and expertise to develop innovative products and services for its customers while also building a strong brand presence. The company has a strong global presence and is able to operate in all major markets. Zimmer Biomet focuses on offering innovative solutions to complex medical problems while providing a high level of customer service and training support. Overall, Zimmer Biomet relies on its reputation and industry knowledge to understand the needs of its customers and provide tailored solutions. The company continues to strive to expand its leadership position in the medical device industry and explore new opportunities for growth and expansion.

Zimmer Biomet Holdings keert een dividend van 0,96 USD uit, verdeeld over 4 betalingen per jaar.

Zimmer Biomet Holdings keert 4 keer per jaar een dividend uit.

De ISIN van Zimmer Biomet Holdings is US98956P1021.

Het WKN van Zimmer Biomet Holdings is 753718.

De ticker van Zimmer Biomet Holdings is ZBH.

Binnen de laatste 12 maanden betaalde Zimmer Biomet Holdings een dividend van 0,96 USD . Dit komt overeen met een dividendrendement van ongeveer 0,88 %. Voor de komende 12 maanden zal Zimmer Biomet Holdings naar verwachting een dividend van 0,97 USD betalen.

De dividendrendement van Zimmer Biomet Holdings is momenteel 0,88 %.

Zimmer Biomet Holdings betaalt elk kwartaal een dividend uit. Dit wordt uitgekeerd in de maanden oktober, januari, april, juli.

Zimmer Biomet Holdings betaalde de afgelopen 18 jaar elk jaar dividend.

Voor de komende 12 maanden wordt een dividend van 0,97 USD verwacht. Dit komt overeen met een dividendrendement van 0,89 %.

Zimmer Biomet Holdings wordt toegewezen aan de sector 'Gezondheid'.

Om het laatste dividend van Zimmer Biomet Holdings van 31-7-2024 ter hoogte van 0,24 USD te ontvangen, moest je het aandeel voor de ex-datum op 26-6-2024 in je portefeuille hebben.

De laatste dividenduitkering vond plaats op 31-7-2024.

In het jaar 2023 heeft Zimmer Biomet Holdings 0,96 USD aan dividenden uitgekeerd.

De dividenden van Zimmer Biomet Holdings worden in USD uitgekeerd.